Study design
This study is a retrospective analysis of all consecutive LTx performed at Harefield Hospital (London, UK) between June 2012 and December 2018. Patients who underwent heart-lung transplantation were excluded from this study. Approval from the Institutional Ethics Committee was obtained, and all the patients provided their written informed consent for LTx as well as for donation after circulatory death (DCD). Data were extracted from the institutional electronic system. Primary endpoints were posttransplant 30-day and 1-year survival. Secondary endpoints were early and mid-term postoperative outcomes.